Testicular lesions span a wide range of conditions, from harmless cysts and benign growths to aggressive cancers that require urgent treatment. A systematic review of small testicular masses found that roughly 41% turned out to be benign and about 59% malignant on final pathology, though the ratio shifts heavily depending on the size of the mass and how it was discovered.1PubMed Central. Prevalence and Management of Incidental Testicular Masses—A Systematic Review That distinction between benign and malignant is the central question every clinician faces when a lump, mass, or abnormality shows up on imaging, and the answer drives everything from whether surgery happens at all to whether a testicle can be saved.
Benign vs. Malignant Lesions and Why Size Matters
One of the most consistent findings across imaging studies is that smaller lesions are far more likely to be harmless. Masses under one centimeter in diameter are benign nearly 70% of the time, according to pooled surgical data.1PubMed Central. Prevalence and Management of Incidental Testicular Masses—A Systematic Review As size increases, so does the probability of cancer. This is why the accidental discovery of a tiny lesion during an ultrasound ordered for something else, like a fertility workup or scrotal pain evaluation, does not automatically mean a worst-case scenario. In one prospective study of men referred for testicular masses, about 73% had malignant tumors and 27% had benign findings, but that cohort was biased toward larger, clinically suspicious masses.2PubMed Central. Discriminating Malignant from Benign Testicular Masses Using Multiparametric Magnetic Resonance Imaging—A Prospective Single-Center Study
The practical takeaway is that size is one of the most useful initial clues. A sub-centimeter lesion discovered incidentally has a good chance of being benign and may be safely followed with repeat imaging rather than immediate surgery. Larger, solid masses with blood flow visible on Doppler ultrasound raise more concern and tend to get a faster surgical referral.
Germ Cell Tumors
The majority of testicular cancers are germ cell tumors, and they fall into two broad families: seminomas and non-seminomatous germ cell tumors. Seminomas tend to occur in men in their 30s and 40s and are composed of cells that resemble the very early germ cells present during embryonic development. Non-seminomatous tumors show a wider variety of tissue types, which can include embryonic-like tissue, yolk sac components, and other patterns.3Annals of Oncology. Testicular germ cell tumours: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up – Section: Pathology Non-seminomas tend to appear slightly younger, often in the late teens through the early 30s.
The distinction matters for treatment. On MRI, seminomas and non-seminomas look different. Seminomas typically appear as solid masses without a capsule and lack the internal bleeding or cystic changes that non-seminomas often show. Non-seminomas are more likely to contain mixed tissue signals on imaging and frequently show areas of hemorrhage or cyst formation.4PubMed Central. Differentiation of testicular seminoma and nonseminomatous germ cell tumor on magnetic resonance imaging Pathologists can also distinguish the two using specific immunohistochemical markers, which helps confirm the diagnosis after tissue removal.5PubMed. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights
Leydig Cell Tumors and Other Stromal Growths
Not all testicular tumors arise from germ cells. A smaller group comes from the support tissue of the testicle itself, particularly the Leydig cells that produce testosterone. Most Leydig cell tumors are benign, but they can cause noticeable hormonal changes. Men with these tumors tend to have lower sperm counts, reduced testicular volume, and hormonal imbalances including elevated levels of certain pituitary hormones and a lower testosterone-to-hormone ratio than men with seminomas.6Human Reproduction. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study – Section: Results Risk factors for Leydig cell tumors include a history of undescended testicle, breast tissue enlargement, and small testicular size.
Because these tumors are usually small and benign, they are strong candidates for testis-sparing surgery rather than removal of the entire testicle, which preserves both the organ and its hormonal function.
Epidermoid Cysts
Among the benign lesions you might hear about, epidermoid cysts are among the most distinctive. These are slow-growing, keratin-filled sacs that sit inside the testicular tissue. They are considered rare but important to recognize because their imaging appearance is so characteristic that an experienced radiologist can often make the diagnosis before surgery.7African Journal of Urology. Testicular epidermoid cyst: about a case report and a review of the literature On ultrasound, they classically show an “onion skin” or “target” pattern of alternating light and dark layers, with no internal blood flow on Doppler.8PubMed Central. Testicular epidermoid cyst: A rare entity – Case report – Section: Discussion
MRI strengthens the diagnosis by showing that the mass does not enhance with contrast dye, a reassuring sign that it lacks the active blood supply tumors need to grow.9PubMed. Sonographic and MR imaging findings of testicular epidermoid cysts Tumor markers like alpha-fetoprotein and beta-hCG come back normal with epidermoid cysts, which further separates them from malignant tumors.8PubMed Central. Testicular epidermoid cyst: A rare entity – Case report – Section: Discussion When the imaging and lab picture is convincing, surgeons can often remove just the cyst and preserve the testicle.
Adenomatoid Tumors
These are the most common benign masses found in the paratesticular region, the structures immediately surrounding the testicle like the epididymis and the tunica. Adenomatoid tumors account for roughly 30% of all paratesticular masses.10PubMed Central. Adenomatoid tumor of testis They grow slowly, rarely cause symptoms, and originate from mesothelial cells, the same tissue type that lines body cavities. Their benign nature is confirmed by pathology after removal, which shows characteristic cell patterns and positive staining for mesothelial markers.11PubMed Central. Primary adenomatoid tumor of the testis: report of a case and review of literature Because they are harmless, surgery is curative and no further treatment is needed.
Segmental Testicular Infarction
Not every lesion is a growth. A portion of the testicle can lose its blood supply, producing a segmental infarction that looks disturbingly like a tumor on imaging. The typical presentation is sudden scrotal pain in a young man, and the initial ultrasound shows an area with no blood flow that can be difficult to distinguish from cancer.12PubMed Central. Segmental Testicular Infarction, an Underdiagnosed Entity: Case Report with Histopathologic Correlation and Review of the Diagnostic Features The cause is usually unknown.13PubMed Central. Segmental testicular infarction: Case series and brief literature review of a great mime
This condition is a genuine diagnostic challenge. It mimics both testicular torsion, where the whole testicle twists on its blood supply, and cancer.14PubMed Central. Segmental testicular infarction: A case report If the clinical suspicion leans toward infarction rather than malignancy, conservative management or an intraoperative biopsy during exploration can confirm the diagnosis and spare the testicle. Some men, however, end up losing the testicle anyway because the imaging overlap with cancer makes conservative management too risky in the surgeon’s judgment.
Inflammatory and Granulomatous Lesions
Infections and inflammatory processes can also produce testicular masses. Granulomatous orchitis, where the testicle develops clusters of inflammatory cells, presents in two ways. An acute form feels like an infection with pain and swelling, while a chronic form produces a hard, painless mass that closely mimics cancer. The differential diagnosis includes tuberculosis, which typically spreads from the prostate as an ascending infection, along with other infections and autoimmune conditions.15Pathology – Research and Practice. Idiopathic granulomatous orchitis – Section: Differential diagnoses When no infectious cause is found, the condition is called idiopathic granulomatous orchitis. The difficulty is that, in its chronic form, it can be indistinguishable from cancer on imaging, and biopsy or surgical exploration may be the only way to get a definitive answer.
Testicular Microlithiasis
Testicular microlithiasis refers to tiny calcium deposits scattered through the testicular tissue, visible as bright spots on ultrasound. It is a common incidental finding, and the question people immediately ask is whether it means cancer. The short answer: by itself, probably not. A study following men with microlithiasis for up to 10 years found that pre-cancerous changes were only detected in men who also had reduced testicular size, and the rate of subsequent cancer development was low. Microlithiasis alone, in a testicle of normal size and shape, did not appear to increase cancer risk.16PubMed Central. Detection of germ cell neoplasia in situ and testicular cancer risk in men with testicular microlithiasis: Real world results through 10 years
Guidelines from the European Society of Urogenital Radiology reflect this. For men who have microlithiasis without any other risk factors, routine follow-up ultrasound is not recommended. Annual ultrasound is suggested up to age 55 only if other risk factors are present, such as a history of undescended testicle, prior testicular cancer, or very small testicular volume. If microlithiasis is found alongside a mass, urgent specialist referral is advised.17PubMed. Testicular microlithiasis imaging and follow-up: guidelines of the ESUR scrotal imaging subcommittee – Section: RESULTS Infertile men with microlithiasis are a special case. One study found an 18-fold increased cancer risk in this group compared to men without microlithiasis, and European guidelines suggest that high-risk infertile men with microlithiasis may be offered a testicular biopsy.18PubMed Central. Diagnostic and prognostic implications of testicular microlithiasis – Section: Management of men with TML, testicular cancer, and infertility
How Testicular Lesions Are Diagnosed
Ultrasound is the first-line imaging tool for any scrotal concern. Standard grayscale ultrasound can identify a mass and characterize basic features like size and echogenicity. Adding color Doppler shows whether a lesion has blood flow, which is one of the strongest clues: most malignancies have increased blood flow, while benign conditions like epidermoid cysts, infarctions, and abscesses characteristically lack it.19PubMed Central. Focal testicular lesions: colour Doppler ultrasound, contrast-enhanced ultrasound and tissue elastography as adjuvants to the diagnosis
Newer ultrasound techniques push diagnostic accuracy further. Contrast-enhanced ultrasound injects microbubbles into the bloodstream to reveal fine vascular patterns, and strain elastography measures tissue stiffness, since cancers tend to be harder than benign tissue. One study found that combining elastography with contrast-enhanced ultrasound reached 100% sensitivity and 93% specificity for telling benign from malignant lesions.20PubMed. Value of Multiparametric US in the Assessment of Intratesticular Lesions Standard color Doppler alone missed about a third of the cancers in that same study, which is why the multiparametric approach has gained ground. When results are still ambiguous, MRI adds another layer, with specific patterns helping distinguish epidermoid cysts, seminomas, and non-seminomas from each other.
Blood-based tumor markers round out the diagnostic picture. The three standard markers are alpha-fetoprotein, lactate dehydrogenase, and human chorionic gonadotropin. None is perfectly specific: alpha-fetoprotein is not elevated in pure seminomas, lactate dehydrogenase can be raised by liver problems and other tissue damage, and hCG goes up in both tumor types. Researchers are exploring whether different molecular forms of hCG, as well as newer molecular markers like circulating microRNAs, could improve the ability to distinguish tumor subtypes before surgery.21PubMed Central. Is Human Chorionic Gonadotropin a Reliable Marker for Testicular Germ Cell Tumor? New Perspectives for a More Accurate Diagnosis
Surgery for Malignant Lesions
When cancer is suspected, the gold standard is radical inguinal orchiectomy, meaning removal of the entire testicle and spermatic cord through a groin incision rather than through the scrotum. The inguinal approach avoids disrupting the scrotal lymphatic drainage, which could otherwise alter the natural path of any potential spread.22PubMed Central. Radical inguinal orchidectomy: the gold standard for initial management of testicular cancer During surgery, frozen-section analysis of the removed tissue provides a rapid assessment of whether the mass is malignant or benign, which is accurate in the vast majority of cases.1PubMed Central. Prevalence and Management of Incidental Testicular Masses—A Systematic Review
Testis-sparing surgery is an alternative for selected patients, particularly when the mass is small, imaging strongly suggests benign disease, or the patient has a solitary testicle where losing it would mean lifelong hormone replacement. A systematic review found that testis-sparing surgery is safe and effective when used according to guidelines, and if a small area of pre-cancerous change is found in the remaining tissue, it can be treated with local radiation.23PubMed. Oncological and functional outcomes of testis sparing surgery in small testicular mass: a systematic review – Section: CONCLUSIONS
Surveillance vs. Adjuvant Treatment After Surgery
For early-stage germ cell tumors that appear confined to the testicle, there is a genuine choice between active surveillance, meaning regular imaging and blood work without further treatment, and adjuvant therapy aimed at reducing the chance of recurrence. Surveillance has become more popular as evidence has mounted about the long-term side effects of unnecessary chemotherapy and radiation in young men.24PubMed Central. Surveillance in testicular cancer: who, when, what and how?
A systematic review comparing the two strategies found that overall survival is virtually the same whether you choose surveillance or adjuvant treatment. The trade-off is that surveillance comes with higher relapse rates, though relapses are nearly always caught early and treated successfully. Shared decision-making is recommended, tailoring the approach to the individual patient’s tumor characteristics and preferences.25PubMed Central. Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review – Section: CONCLUSION For non-seminomas with certain higher-risk features like lymphovascular invasion, a single cycle of chemotherapy has been used to reduce recurrence risk. For seminomas, options have included radiation, a single dose of carboplatin, or surveillance, with the choice shifting over time toward less aggressive approaches.26PubMed. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors – a review and the SWENOTECA experience
Fertility and Hormonal Health After Treatment
Fertility is one of the major concerns for men treated for testicular lesions, especially malignant ones. Even before any treatment, some men with testicular cancer already have below-normal sperm quality. After orchiectomy alone with no further treatment, about 41% have elevated levels of follicle-stimulating hormone, a marker of impaired sperm production, and about 11% have low testosterone.27PubMed Central. Fertility, gonadal and sexual function in survivors of testicular cancer
Adding chemotherapy or radiation worsens these numbers, though testosterone levels are generally more resilient than sperm counts. Research following men after cisplatin-based chemotherapy found that roughly half to 60% regained active sperm production within one to three years of finishing treatment, and a meaningful number went on to father children naturally.28PubMed. Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production Still, recovery is not guaranteed, which is why sperm banking before treatment is strongly recommended. Families and patients should be informed about the variable effects of different treatments on future fertility so they can make decisions about preservation beforehand.29PubMed Central. Fertility considerations in men with testicular cancer
Testicular Lesions in Children
The landscape of testicular lesions is different in children than in adults. Before puberty, benign tumors are more common than malignant ones, which is the reverse of the adult pattern. Mature teratoma is the most frequent histologic type in prepubertal boys. After puberty, the balance shifts and malignant germ cell tumors become more common.30PubMed Central. Testicular tumours in children: an approach to diagnosis and management with pathologic correlation
This age-dependent difference has practical implications. Because benign lesions dominate in younger boys, testis-sparing surgery has gained significant traction in pediatric cases. The traditional approach had been to follow adult protocols and remove the entire testicle, but as evidence accumulated that most childhood lesions are benign, organ preservation became a more prominent goal.31PubMed Central. Frozen-section examination in the management of paediatric testicular lesions Frozen-section analysis during surgery allows surgeons to get a rapid pathology read before deciding whether to remove the testicle or just excise the lesion. When the frozen section confirms benign tissue, the testicle stays.
Genetic and Environmental Risk Factors
Testicular germ cell tumors have a notable familial component. Brothers of affected men carry a substantially elevated risk, and sons of affected fathers have a moderately increased risk as well. Genome-wide studies have identified several genes that modify susceptibility, including genes involved in germ cell development and survival.32Endocrine-Related Cancer. Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype The interplay between genes, hormones, and environment is complex, and current understanding treats these risk factors as mutually reinforcing rather than independent.33PubMed Central. Testicular Cancer: Genes, Environment, Hormones
On the environmental side, endocrine-disrupting chemicals have drawn particular attention. A systematic review and meta-analysis found that maternal exposure to these chemicals during pregnancy was associated with roughly double the risk of testicular cancer in male offspring. The association was strongest for non-seminomas, where risk was nearly tripled. Interestingly, adult male exposure to the same chemicals after birth showed inconsistent effects, suggesting that the vulnerable window is fetal development rather than adulthood.34PubMed Central. Endocrine Disrupting Chemicals and Risk of Testicular Cancer: A Systematic Review and Meta-analysis These findings align with a broader body of evidence linking prenatal exposure to endocrine disruptors with male reproductive abnormalities, including genital malformations and reduced sperm quality.35PubMed Central. Environmental causes of cancer: endocrine disruptors as carcinogens
Body Image, Sexual Function, and Life After Treatment
Testicular cancer has among the highest cure rates of any solid tumor, and most survivors rate their overall quality of life as good or comparable to healthy men. But that headline number masks a more complicated picture for a significant minority. About 17% of long-term survivors report changes in body image, often related to feeling less masculine or being anxious about others noticing a missing testicle. These body image concerns are linked to all measured dimensions of sexual difficulty, including reduced interest, reduced activity, erectile problems, and ejaculatory dysfunction.36PubMed. Sexuality and body image in long-term survivors of testicular cancer – Section: RESULTS
Among specific treatments, retroperitoneal lymph node dissection stands out as a procedure associated with ejaculatory problems, because the surgery can damage the nerves that control ejaculation. Overall, about a quarter of survivors report reduced sexual interest and over 40% report reduced sexual activity, though these numbers improve over time for many men.37PubMed Central. Psychosocial Issues in Long-Term Survivors of Testicular Cancer – Section: Results Prosthetic testicular implants are available for men who want to restore a normal appearance, and counseling about sexual health is increasingly recognized as an important part of survivorship care rather than an afterthought. Most survivors do not report feeling less attractive or less masculine in the long run, but the fact that a persistent minority does underscores the value of proactive psychological support in the months and years following treatment.